Local Co-Delivery of Pancreatic Islets and Liposomal Clodronate Using Injectable Hydrogel to Prevent Acute Immune Reactions in a Type 1 Diabetes

ABSTRACTPurposeThe purpose of this study was to investigate the effect of locally delivered pancreatic islet with liposomal clodronate (Clodrosome®) as an immunoprotection agent for the treatment of type 1 diabetes.MethodThe bio-distribution of liposomal clodronate in matrigel was checked by imaging analyzer. To verify the therapeutic efficacy of locally delivered islet with liposomal clodronate using injectable hydrogel, four groups of islet transplanted mice (n = 6 in each group) were prepared: 1) the islet group, 2) the islet-Clodrosome group, 3) the islet-Matrigel group, and 4) the islet-Matrigel-Clodrosome group. Immune cell migration and activation, and pro-inflammatory cytokine secretion was evaluated by immunohistochemistry staining and ELISA assay.ResultsCy5.5 labeled liposomes remained in the matrigel for over 7 days. The median survival time of transplanted islets (Islet-Matrigel-Clodrosome group) was significantly increased (>60 days), compared to other groups. Locally delivered liposomal clodronate in matrigel effectively inhibited the activation of macrophages, immune cell migration and activation, and pro-inflammatory cytokine secretion from macrophages.ConclusionsLocally co-delivered pancreatic islets and liposomal clodronate using injectable hydrogel effectively cured type 1 diabetes. Especially, the inhibition of macrophage attack in the early stage after local delivery of islets was very important for the successful long-term survival of delivered islets.

[1]  A. Blomqvist,et al.  Inducible Prostaglandin E2 Synthesis Interacts in a Temporally Supplementary Sequence with Constitutive Prostaglandin-Synthesizing Enzymes in Creating the Hypothalamic–Pituitary–Adrenal Axis Response to Immune Challenge , 2009, The Journal of Neuroscience.

[2]  E. Lewis,et al.  α-1-Antitrypsin Gene Delivery Reduces Inflammation, Increases T-Regulatory Cell Population Size and Prevents Islet Allograft Rejection , 2011, Molecular medicine.

[3]  Haitao Zhu,et al.  Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival , 2013, PloS one.

[4]  Z. Guan,et al.  Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel. , 2013, Biomaterials.

[5]  L. Harrison,et al.  Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. , 1998, Transplantation.

[6]  J. Mönkkönen,et al.  Cellular uptake and metabolism of clodronate and its derivatives in Caco-2 cells: a possible correlation with bisphosphonate-induced gastrointestinal side-effects. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  R. Lechler,et al.  Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. , 2005, Diabetes.

[8]  J. Mönkkönen,et al.  Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  John G. Graham,et al.  Advancing islet transplantation: from engraftment to the immune response , 2011, Diabetologia.

[10]  Kai-Chiang Yang,et al.  Chitosan/gelatin hydrogel as immunoisolative matrix for injectable bioartificial pancreas , 2008, Xenotransplantation.

[11]  O. Korsgren,et al.  Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood‐mediated inflammatory reaction , 2004, Xenotransplantation.

[12]  H. Ljunggren,et al.  Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. , 1996, Transplantation.

[13]  C. Ricordi,et al.  Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. , 1998, Diabetes.

[14]  J. Mönkkönen,et al.  Clodronate and Liposome‐Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′‐(β,γ‐Dichloromethylene) Triphosphate, by Mammalian Cells In Vitro , 1997 .

[15]  R. Lanza,et al.  Xenotransplantation of cells using biodegradable microcapsules. , 1999, Transplantation.

[16]  W. R. Taylor,et al.  Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. , 2013, Biomaterials.

[17]  O. Korsgren,et al.  Pig islet xenograft rejection is markedly delayed in macrophage‐depleted mice: a study in streptozotocin diabetic animals , 2000, Xenotransplantation.

[18]  Z. Kaleem,et al.  Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway , 2002, Xenotransplantation.

[19]  N. Van Rooijen,et al.  Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts , 2003, Current eye research.

[20]  P. de Vos,et al.  Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats , 2003, Xenotransplantation.

[21]  M. Goosen,et al.  Injectable microencapsulated islet cells as a bioartificial pancreas , 1984, Applied biochemistry and biotechnology.

[22]  P. Marrack,et al.  Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. , 2003, Blood.

[23]  J. Stockman,et al.  International Trial of the Edmonton Protocol for Islet Transplantation , 2008 .